Collegium Pharmaceutical
COLL
Cars.com
CARS
Halozyme Therapeutics
HALO
4
Lantheus
LNTH
5
Hutchmed (China)
HCM
US Stock MarketDetailed Quotes
GWRE Guidewire Software
- 203.629
- +4.059+2.03%
Trading Apr 29 12:34 ET
17.08BMarket Cap-1018.15P/E (TTM)
204.510High199.967Low334.86KVolume200.050Open199.570Pre Close68.09MTurnover0.40%Turnover RatioLossP/E (Static)83.88MShares219.59052wk High13.46P/B16.98BFloat Cap107.65052wk Low--Dividend TTM83.37MShs Float219.590Historical High--Div YieldTTM2.28%Amplitude16.450Historical Low203.341Avg Price1Lot Size
Guidewire Software Key Stats
Quarterly+Annual
YOY
| (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 24.17%85.99M | 13.56%-62.31M | 409.83%195.75M | 11.86%193.78M | 109.88%4.8M | 5,576.31%69.25M | 17.56%-72.08M | 201.20%38.4M | 107.24%173.24M | -323.58%-48.63M |
| Net income from continuing operations | -484.81%-37.28M | 133.76%9.14M | 94.54%-6.1M | 37.14%16.76M | 87.98%-5.48M | 205.42%9.69M | 60.95%-27.07M | 38.01%-111.86M | 139.38%12.22M | 20.67%-45.57M |
| Operating gains losses | ---- | ---- | ---1.8M | ---45K | --0 | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 4.30%5.73M | 7.41%5.85M | -10.18%22.31M | 17.39%5.78M | -1.60%5.59M | -16.86%5.49M | -28.61%5.44M | -25.95%24.84M | -36.79%4.93M | -35.18%5.68M |
| Deferred tax | -48.78%-6.2M | 39.83%-7.96M | 2.43%-26.85M | -30.44%2.45M | 6.09%-11.9M | -1,191.02%-4.17M | 26.70%-13.22M | 49.15%-27.52M | 152.84%3.52M | 26.34%-12.68M |
| Other non cash items | 10.44%5.63M | 33.71%5.97M | -31.27%19.47M | -8.36%5.38M | -64.99%4.53M | 11.41%5.1M | -9.74%4.47M | -1.99%28.34M | -28.80%5.87M | 84.17%12.94M |
| Change In working capital | 37.91%30.47M | -48.46%-111.34M | 474.55%52.67M | 13.50%126.64M | 50.19%-21.07M | 162.13%22.1M | -56.98%-75M | -49.52%-14.06M | 54.90%111.58M | -498.97%-42.3M |
| -Change in receivables | 32.51%-11M | -100.70%-280K | 197.93%20.31M | -63.34%7.99M | 61.71%-11.33M | 65.71%-16.29M | 15.49%39.94M | 15.15%-20.74M | 201.24%21.79M | -641.08%-29.59M |
| -Change in prepaid assets | 6.98%-5.55M | 4.10%-6.29M | -48.30%-33.53M | -15.74%-11.45M | -20.93%-9.55M | -49.99%-5.97M | -681.88%-6.56M | 3.32%-22.61M | -1.74%-9.9M | -2,300.61%-7.9M |
| -Change in payables and accrued expense | -81.66%3.61M | 43.63%-40.34M | -296.23%-12.48M | -24.83%23.66M | 61.95%15.73M | 99.42%19.69M | -60.08%-71.56M | 37.13%6.36M | -3.46%31.48M | -53.90%9.71M |
| -Change in other current assets | -155.37%-1.15M | -10.86%1.76M | 145.38%8.62M | 132.89%2.52M | 112.75%2.06M | 99.52%2.08M | -47.69%1.97M | -365.36%-19M | -801.30%-7.65M | -789.84%-16.16M |
| -Change in other current liabilities | 357.95%3.98M | -797.78%-8.08M | -138.66%-2.82M | -71.81%3.35M | -179.23%-3.72M | 31.75%-1.54M | 87.17%-900K | 247.67%7.29M | 35.82%11.86M | 203.21%4.7M |
| -Change in other working capital | 68.14%40.59M | -53.34%-58.11M | 109.53%72.57M | 57.17%100.58M | -364.52%-14.26M | 231.37%24.14M | -12.86%-37.89M | 9.73%34.64M | 1.93%64M | 77.08%-3.07M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 24.17%85.99M | 13.56%-62.31M | 409.83%195.75M | 11.86%193.78M | 109.88%4.8M | 5,576.31%69.25M | 17.56%-72.08M | 201.20%38.4M | 107.24%173.24M | -323.58%-48.63M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -125.89%-52.92M | -179.21%-77.6M | -511.89%-52.36M | -182.32%-7.29M | -88.32%6.15M | -519.76%-23.43M | 48.93%-27.79M | -95.93%12.71M | -95.51%8.86M | -37.10%52.7M |
| Capital expenditure reported | -23.54%-2.92M | -14.65%-4.23M | -4.82%-12.17M | -0.26%-2.74M | -22.18%-3.37M | 2.27%-2.37M | 0.14%-3.69M | 5.38%-11.61M | 11.37%-2.73M | 7.73%-2.76M |
| Net PPE purchase and sale | 73.60%-790K | 15.53%-843K | -9.29%-6.36M | 47.18%-1.69M | -0.15%-678K | -124.46%-2.99M | -65.23%-998K | 38.79%-5.82M | -109.06%-3.21M | 31.34%-677K |
| Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net investment purchase and sale | -172.33%-49.21M | -213.92%-72.53M | -212.25%-33.83M | -119.35%-2.86M | -81.82%10.2M | -293.56%-18.07M | 53.91%-23.1M | -92.02%30.14M | -92.68%14.79M | -36.04%56.13M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -125.89%-52.92M | -179.21%-77.6M | -511.89%-52.36M | -182.32%-7.29M | -88.32%6.15M | -519.76%-23.43M | 48.93%-27.79M | -95.93%12.71M | -95.51%8.86M | -37.10%52.7M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -3,889,875.00%-155.59M | 415.51M | 100.40%1.06M | 102.18%1.04M | 100.07%10K | 100.00%4K | 0 | -600.63%-261.58M | -47.81M | -76,588.89%-13.77M |
| Net issuance payments of debt | ---154.05M | --472.36M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -599.07%-261.81M | ---47.81M | ---13.99M |
| Proceeds from stock option exercised by employees | 13,025.00%525K | --1.94M | 362.72%1.06M | 104,000.00%1.04M | -95.56%10K | --4K | --0 | 96.55%228K | --1K | 1,150.00%225K |
| Net other financing activities | ---2.07M | ---58.79M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -3,889,875.00%-155.59M | --415.51M | 100.40%1.06M | 102.18%1.04M | 100.07%10K | 100.00%4K | --0 | -600.63%-261.58M | ---47.81M | -76,588.89%-13.77M |
| Net cash flow | ||||||||||
| Beginning cash position | 172.55%824.75M | 35.00%549.18M | -33.82%406.79M | 32.84%360.79M | 24.72%351.18M | 12.15%302.61M | -33.82%406.79M | 59.70%614.69M | -18.97%271.59M | 5.98%281.57M |
| Current changes in cash | -367.35%-122.52M | 375.94%275.6M | 168.63%144.44M | 39.65%187.53M | 213.06%10.97M | 573.64%45.83M | 70.78%-99.88M | -188.83%-210.47M | -52.22%134.28M | -113.41%-9.7M |
| Effect of exchange rate changes | -229.61%-3.55M | 99.28%-31K | -179.58%-2.05M | -5.67%865K | -380.14%-1.35M | -44.42%2.74M | -43.82%-4.3M | 135.97%2.58M | 160.33%917K | 90.05%-282K |
| End cash Position | 98.95%698.68M | 172.55%824.75M | 35.00%549.18M | 35.00%549.18M | 32.84%360.79M | 24.72%351.18M | 12.15%302.61M | -33.82%406.79M | -33.82%406.79M | -18.97%271.59M |
| Free cash flow | 28.77%82.28M | 12.23%-67.38M | 745.20%177.22M | 13.18%189.35M | 101.45%754K | 2,621.43%63.89M | 16.31%-76.77M | 135.11%20.97M | 111.83%167.3M | -236.85%-52.06M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀